Log in to save to my catalogue

Research Advances of EGFR-TP53 Co-mutation in Advanced Non-small Cell Lung Cancer

Research Advances of EGFR-TP53 Co-mutation in Advanced Non-small Cell Lung Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cb7c4d61dd33499280176f0aa7879640

Research Advances of EGFR-TP53 Co-mutation in Advanced Non-small Cell Lung Cancer

About this item

Full title

Research Advances of EGFR-TP53 Co-mutation in Advanced Non-small Cell Lung Cancer

Author / Creator

Publisher

China: Chinese Anti-Cancer Association Chinese Antituberculosis Association

Journal title

Zhongguo fei ai za zhi, 2022-03, Vol.25 (3), p.174-182

Language

Chinese

Formats

Publication information

Publisher

China: Chinese Anti-Cancer Association Chinese Antituberculosis Association

More information

Scope and Contents

Contents

With the rapid development and wide application of next generation sequencing (NGS) technology, a series of researches have revealed that concurrent genetic alterations play an important role in the response and resistance of epidermal growth factor receptor (EGFR)-mutant NSCLC to EGFR-tyrosine kinase inhibitor (TKI). Besides, TP53 mutation is the...

Alternative Titles

Full title

Research Advances of EGFR-TP53 Co-mutation in Advanced Non-small Cell Lung Cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cb7c4d61dd33499280176f0aa7879640

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cb7c4d61dd33499280176f0aa7879640

Other Identifiers

ISSN

1009-3419,1999-6187

E-ISSN

1999-6187

DOI

10.3779/j.issn.1009-3419.2022.101.06

How to access this item